UnitedHealth Stock Has Gone Nowhere for Five Years. Its Dividend Has Not
UnitedHealth shareholders spent five years waiting for a stock that barely budged, yet something inside the company kept growing the whole time. Whether that something is enough to make UNH worth holding now depends on costs that management has not…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Five years of owning UnitedHealth (NYSE:UNH | UNH Price Prediction) have produced a share price gain of just 3.30%. Over that same stretch, the company raised its dividend every year. The quarterly payout now stands at $2.32, or $9.28 annualized. The recent trend is healthy: shares are up 16.70% year to date and 12.72% over the past year, trading at $377.83. The longer window tells a different story. The stock has barely compounded, and the payout did the work the share price did not.
Raises Kept Coming Through the Company’s Worst Stretch
In mid-2021, UnitedHealth paid $1.45 per quarter. That climbed to $1.65 in 2022, $1.88 in 2023, $2.10 in 2024 and $2.21 in 2025. The dividend record shows an increase every year since 2010.
The latest raise from $2.21 to $2.32 arrived after a brutal 2025. The third-quarter medical care ratio surged to 89.9% and operating income fell 50.45%. In the fourth quarter, a $2.88 billion pre-tax charge cut GAAP EPS to $0.01. Chief Executive Stephen Hemsley framed the year this way:
“We confronted challenges directly and finished 2025 as a much stronger company, giving us the momentum to better serve those who count on us and continue to improve our core performance.”
A Flat Five Years Hides a Sharp Recovery
The price path inside 2026 has been steep. Shares sat at $282.59 at the January earnings release, $325.02 in April and $415.70 in July. The 52-week range runs from $252.96 to $458.79.
A shareholder counting on price appreciation over five years collected almost nothing. The income holder banked $9.06 per share in the past twelve months alone (the whole idea behind a dividend ladder built to fund retirement without selling shares, which we laid out in a free guide here).
Peers look weaker on income. Humana (NYSE:HUM) said it would maintain the dividend flat and guided 2026 adjusted EPS to at least $9.00, down from $17.14. Elevance Health (NYSE:ELV) nudged its quarterly payout to $1.72 from $1.71.
Cash Flow Covers the Payout, but Medical Costs Loom
In 2025, UnitedHealth generated $19.697 billion in operating cash flow against $3.622 billion of capital spending and $7.916 billion in dividends. For 2026, it guides to roughly $24 billion of operating cash flow, about $8 billion in dividends and buybacks of at least $5 billion. Debt to capital fell to 41.2% from 44.1%. On the July call, management said:
“The durability of the underlying run rate is strong and you can see that in our cash flows.”
The threats sit in the cost line. Commercial trend is running “modestly above 11%”, and management conceded:
“We’re not yielding the full margin expansion for which we planned in 2026.”
Medicaid margins are guided to negative 1 to negative 1.7%, and DOJ actions concerning Medicare participation remain open. Second-quarter results also leaned on $860 million of favorable reserve development.
Verdict: A Dividend Built for Income Investors
At a 2.38% yield, UnitedHealth is a moderate payer rather than a high-yield one. Its value is the raise pace, and cash flow still comfortably supports it. As an income holding, the case holds up. Keep an eye on the 88.1% medical care ratio target and 2027 Medicare bids.
Contact [email protected] for any questions or corrections.
Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.
His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.
When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.
